Sign in
4

Changes in Ownership

RHYTHM PHARMACEUTICALS, INC. Filed Acc 0001104659-25-033821

Chief Human Resources Officer sold 20,760 shares at an average $60.14 ($1,248,490)

  • Chief Human Resources Officer acquired 20,760 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Cramer Pamela J. Chief Human Resources Officer 2025-04-08 Option exercise 10b5-1 +14,060 $6.80 $95,608 33,269 D: show line 1 in the form
Cramer Pamela J. Chief Human Resources Officer 2025-04-08 Option exercise 10b5-1 +6,700 $27.35 $183,245 39,969 D: show line 2 in the form
Cramer Pamela J. Chief Human Resources Officer 2025-04-08 Sale 10b5-1 −6,430 $58.36 $375,230 33,539 D: show line 3 in the form
Cramer Pamela J. Chief Human Resources Officer 2025-04-08 Sale 10b5-1 −600 $59.00 $35,400 32,939 D: show line 4 in the form
Cramer Pamela J. Chief Human Resources Officer 2025-04-08 Sale 10b5-1 −6,700 $60.00 $402,000 26,239 D: show line 5 in the form
Cramer Pamela J. Chief Human Resources Officer 2025-04-08 Sale 10b5-1 −7,030 $62.00 $435,860 19,209 D: show line 6 in the form
Open-market sales · 20,760 sh · avg $60.14 · $1,248,490

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Cramer Pamela J. Chief Human Resources Officer 2025-04-08 Option exercise · Stock Options (Right to Buy) 10b5-1 +14,060 42,190 D: show line 7 in the form
Cramer Pamela J. Chief Human Resources Officer 2025-04-08 Option exercise · Stock Options (Right to Buy) 10b5-1 +6,700 20,100 D: show line 8 in the form
Loading xslF345X05/tm2512047-2_4seq1.xml…